Sign in

InFLAMES Research Flagship

@inflames-flagship.bsky.social
291 followers 522 following 161 posts

Research and Innovation Flagship aiming at being an internationally recognized, top-level, immunological research and development cluster.

PostsRepliesMedia
InFLAMES Research Flagship @inflames-flagship.bsky.social · 28/08/2026
📢We are proud to announce that next week, we will be welcoming the following InFLAMES Flagship SIAB members to visit Finland: Professor Eugene Butcher (Stanford University, USA), Professor Yvette van Kooyk (Amsterdam UMC, the Netherlands) and Managing Director Jeffrey Bluestone (Vie Ventures, USA).
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 27/08/2026
Our researchers in the University of Turku in Finland with colleagues in @gustaveroussy.fr have discovered a molecular mechanism that regulates whether the cells of an aggressive colorectal cancer are conventional or inverted when they spread in the body. This is a truly amazing discovery🔥!
inflames.utu.fi
Researchers discover molecular mechanism that helps aggressive colorectal cancer to spread – InFLAMES Research Flagship
000
InFLAMES Research Flagship @inflames-flagship.bsky.social · 27/08/2026
Tutkijamme ovat tunnistaneet mekanismin, jolla yksi suolistosyöpätyypeistä helpottaa leviämistään elimistössä. Avainasemassa on syöpäsolujen kyky olla joko oikein- tai nurinpäin. Löytö tarjoaa mahdollisuuksia kehittää tulevaisuudessa keinoja syövän leviämisen hillitsemiseen. Johanna Ivaska
utu.fi
Tutkijat löysivät molekyylikytkimen, joka auttaa aggressiivista suolistosyöpää leviämään
Turun yliopiston biotiedekeskuksen ja Pariisin Gustave Roussy -instituutin tutkijat ovat löytäneet molekyylitason mekanismin, joka ratkaisee, ovatko aggressiivisen suolistosyövän solut oikein- vai
030
Reposted by InFLAMES Research Flagship
juhalaine8.bsky.social @juhalaine8.bsky.social · 20/08/2026
Perinteinen lääkekehityksen kassavirtakäyrä on liian deterministinen. Todellisuus on kliinisiä epäonnistumisia, kilpailua ja satunnaisia jättimenestyksiä. Lääke- ja bioteknologia-ala on Suomessa vahvassa kasvussa. Menestys vaatii rohkeutta ja panostusta 👉 tinyurl.com/2w35ccpr
tinyurl.com
From a cash flow curve to a distribution of possible futures
Gregson et al. published an interesting article in 2005 entitled Pricing medicines: theory and practice, challenges and opportunities.
011
Reposted by InFLAMES Research Flagship
The Lancet @thelancet.com · 13/08/2026
What could personalised cancer prevention look like in practice? Prof. Timothy R. Rebbeck will explore how risk-stratified approaches can identify the right person, time, and intervention to prevent cancer. 👉 Register for the lecture today: spkl.io/633247yTK4
Register to attend the Gustave Roussy-Lancet Lecture Series on Sept 18. Copyright: Gustave Roussy.
043
InFLAMES Research Flagship @inflames-flagship.bsky.social · 17/08/2026
🔥📢The second call for applications to the IMMUFELLOW Postdoctoral Fellowship Programme is open. A total of 11 positions are available for international postdoctoral researchers at the University of Turku and Åbo Akademi University, Finland. #immunology #ImmunoSky #AcademicSky #MedSky
inflames.utu.fi
11 Postdoctoral Researcher Positions Open in the EU-Funded IMMUFELLOW Training Programme – InFLAMES Research Flagship
010
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 11/08/2026
📣 REGISTER THIS FRIDAY to 35th BioCity Symposium: VISION, EXPANDED bit.ly/4f6kuUR 27-28 August 2026 in BioCity, Turku, Finland Welcome everyone! @utu.fi @turkubioimaging.bsky.social @eurobioimaging.bsky.social @turkubioscience.bsky.social @inflames-flagship.bsky.social
022
InFLAMES Research Flagship @inflames-flagship.bsky.social · 07/08/2026
📢WE are hiring! We seek to appoint up to two highly motivated and collaborative Research Managers to support the development, competitiveness, and long-term impact of our flagship’s research and innovation activities. Check this out! #ImmunoSky #Science #FinnishFlagships
ats.talentadore.com
Research Managers to the InFLAMES Flagship (up to two positions)
We are looking for up to two Research Managers (temporary positions). The InFLAMES Research Flagship (https://inflames.utu.fi/ ) at the University of Turku (https://www.utu.fi/en ) is seeking to appoi...
120
InFLAMES Research Flagship @inflames-flagship.bsky.social · 13/07/2026
Nobel laureate Shimon Sakaguchi visited the University of Turku in the spring of 2026. We discussed T-cell research with him and the potential applications of these cells in the treatment of autoimmune diseases. Watch the full interview here👉 www.youtube.com/watch?v=emJxKb7HIkw…
000
InFLAMES Research Flagship @inflames-flagship.bsky.social · 01/07/2026
Pitäisikö Turun olla Medical City? Kansanedustaja Aki Lindén muistutti InFLAMES-paneelissa SuomiAreenassa, että lääkeala ja diagnostiikka ovat Turussa suuria työllistäjiä.
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 29/06/2026
Our research team has developed a reliable laboratory model to study BAP1-deficient melanomas, which are a rare type of #melanoma that evade the immune system once they have metastasized and are universally resistant to current state-of-the-art #immunotherapies. #MIORG @utu.fi
inflames.utu.fi
New laboratory tool opens door to better treatments for rare and deadly melanomas - InFLAMES Research Flagship
Researchers have created a powerful new cellular model to study rare tumours that are resistant to immunotherapies. The tool could change how therapies are developed for aggressive melanomas that curr...
030
InFLAMES Research Flagship @inflames-flagship.bsky.social · 26/06/2026
SuomiAreenassa nyt: InFLAMES! Voiko lääketiede olla vaurauden sampo? Katsotaan... @utu.fi @aboakademi.bsky.social
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 16/06/2026
ORATORIO-HAND trial showed that ocrelizumab reduced the risk of disability progression versus placebo in patients with primary progressive multiple sclerosis (PPMS). Second writer of the article is InFLAMES PI, Professor of Neuroimmunology Laura Airas, @utu.fi
110
InFLAMES Research Flagship @inflames-flagship.bsky.social · 16/06/2026
Olemme mukana SuomiAreenassa perjantaina 26.6.! Tule Puuvillan lavalle kello 11:00 kuuntelemaan yksi tapahtuman mielenkiintoisimmista keskusteluista! @utu.fi @aalto.fi @orionpharma.bsky.social
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 10/06/2026
Former Genentech Director Andy Chan is our Visiting Professor and he has been us now nearly for a week. We are happy for our young researchers, who have had lively discussions and inspiring seminars with Andy. Thank you Andy, you are a great mentor! #ImmunoSky #MedSky #immunology #science @utu.fi
A portrait
040
InFLAMES Research Flagship @inflames-flagship.bsky.social · 02/06/2026
We are so lucky, we have brilliant Professor David G Shazt from Yale School of Medicine as keynote speaker at ImmuDocs and IFDM summer seminar! Cool! #ImmunoSky #MedSky #FinnishFlagships @utu.fi
020
InFLAMES Research Flagship @inflames-flagship.bsky.social · 01/06/2026
A huge THANK YOU to everyone who made our Corporate Corner event truly special — our brilliant speakers, our fantastic chairs, and every single member of the audience who showed up, asked great questions, and brought so much energy to the room. @caixaresearch.bsky.social @univ-amu.fr @utu.fi
Group of happy people posinf to camera.
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 01/06/2026
Lääketiede voi olla vaurauden sampo - tai hukattu mahdollisuus. Keskustellaan SuomiAreenassa juhannuksen jälkeen 26.6.!
000
InFLAMES Research Flagship @inflames-flagship.bsky.social · 27/05/2026
InFLAMES Corporate Corner is on! We discuss Immunology bioclusters driving economic growth. Exciting! @utu.fi
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 26/05/2026
Uusi aivokuvantamistutkimus ei löytänyt pitkittyneistä koronataudin oireista kärsivien potilaiden aivoista laaja-alaista aivotulehdusta. Sen sijaan voimakkaimmat long covid-oireet olivat yhteydessä lisääntyneeseen aktivaatioon alueilla, jotka liittyvät mielialaan ja tunteisiin. #ImmunoSky #TSPO-PET
inflames.utu.fi
Aivotulehdus on epätodennäköinen syy pitkittyneisiin koronaoireisiin - InFLAMES-lippulaiva
Uusi aivokuvantamistutkimus ei löytänyt pitkittyneistä koronataudin oireista kärsivien potilaiden aivoista laaja-alaista aivotulehdusta. Sen sijaan voimakkaimmat long covid-oireet olivat yhteydessä li...
000
InFLAMES Research Flagship @inflames-flagship.bsky.social · 26/05/2026
A new brain imaging study has found no evidence of widespread brain inflammation in patients suffering from prolonged symptoms after COVID-19 infection. Instead, the most severe long COVID symptoms were associated with increased brain activity in regions involved in mood and emotion.
inflames.utu.fi
Brain inflammation is unlikely to explain persistent long COVID symptoms - InFLAMES Research Flagship
A new brain imaging study has found no evidence of widespread brain inflammation in patients suffering from prolonged symptoms after COVID-19 infection. Instead, the most severe long COVID symptoms we...
001
InFLAMES Research Flagship @inflames-flagship.bsky.social · 20/05/2026
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 20/05/2026
A week to go...we are In🔥s!
020
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 18/05/2026
#biocityturkuannouncement 21/26 This week * Bioinformatics Webinar * MBC Bioinformatics Consultation * InFLAMES Guest Seminar * EDISS Research Project Seminar * Frontiers of Science * FICAN West Guest Seminar * Infectomics Seminar ...and more: bit.ly/4vf8s0z @utu.fi @inflames-flagship.bsky.social
041
InFLAMES Research Flagship @inflames-flagship.bsky.social · 14/05/2026
We had an honour to talk with Nobel laureate, professor Shimon Sakaguchi during his visit to the University of Turku. He explained which research finding was key to his discovery of regulatory T-cells and how he now views the clinical relevance of this cell type. #ImmunoSky @lahesmaalab.bsky.social
inflames.utu.fi
Regulatory T cells discovered by Shimon Sakaguchi maintain order in the body - InFLAMES Research Flagship
By the late 1980s, immunologists had had enough and walked away from suppressor T cells. Researchers had reached a dead end in their attempts to study them and no longer believed in the very existence...
020
InFLAMES Research Flagship @inflames-flagship.bsky.social · 14/05/2026
Tapasimme nobelistin, professorin ja maailmankuulun immunologin Shimon Sakaguchin hänen vieraillessaan Turun yliopistossa. Hän kertoi, mikä tutkimus oli hänen T-säätelijäsolulöydölleen ratkaiseva ja antoi myös neuvoja nuoremmille tutkijoille. #ImmunoSky #MedSky @lahesmaalab.bsky.social
inflames.utu.fi
Nobelisti Shimon Sakaguchin löytämä T-säätelijäsolu on elimistön järjestyksenvalvoja - InFLAMES-lippulaiva
Immunologit saivat tarpeekseen joskus 1980-luvun lopulla ja käänsivät selkänsä supressori T-solulle. Yritykset tutkia sitä olivat johtaneet umpikujaan, solun olemassa oloon ei edes enää uskottu. Turha...
010
Reposted by InFLAMES Research Flagship
Elo Lab @elolab.bsky.social · 12/05/2026
Our group had the honor of meeting a Nobel laureate Prof. Shimon Sakaguchi during his visit to University of Turku. Thank you for the inspiring and thought-provoking discussions! @turkubioscience.bsky.social @inflames-flagship.bsky.social @utu.fi
061
InFLAMES Research Flagship @inflames-flagship.bsky.social · 12/05/2026
Full house in Turku for Nobel Laureate, Professor Shimon Sakaguchi. It's such a honor to have him here! #MedSky #ImmunoSky #Science @utu.fi @lahesmaalab.bsky.social
040
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 11/05/2026
#biocityturkuannouncement 20/26 This and next week * BioCity Turku Guest Seminar, Nobelist Shimon Sakaguchi * Bioinformatics Webinar Series * Gene and Cell Therapy Workshop * Frontiers of Science * FICAN West Guest Seminar * Infectomics Seminar bit.ly/4dFbhAT @utu.fi @inflames-flagship.bsky.social
021
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 07/05/2026
BioCity Turku early-career researchers will this year arrange *2nd BioCity Pre-Symposium* on Wednesday 26 August afternoon. ☕🍷🥙🍩, posters and networking: bit.ly/4uyKmNU Spread the word and come along! @utu.fi @inflames-flagship.bsky.social @turkubioimaging.bsky.social @turkubioscience.bsky.social
031
InFLAMES Research Flagship @inflames-flagship.bsky.social · 08/05/2026
Nobel-palkittu professori Shimon Sakaguchi luennoi Turun yliopistossa tiistaina 12.5. Sakaguchin löydökset ovat luoneet uusia mahdollisuuksia muun muassa syöpien ja autoimmuunisairauksien hoitojen kehittämiseen. #MedSky #ImmunoSky #Treg Lahesmaa Lab Turku Bioscience
utu.fi
Nobelisti, professori Shimon Sakaguchi vierailee Turun yliopistossa
Vuonna 2025 lääketieteen Nobelilla palkittu professori Shimon Sakaguchi luennoi Turun yliopistossa 12. toukokuuta.
010
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 06/05/2026
👉ONE MONTH TIME to submit an abstract to 35th BioCity Symposium: VISION, EXPANDED bit.ly/4f6kuUR Come and see some amazing imaging here in Turku, 27-28 August! @utu.fi @turkubioimaging.bsky.social @eurobioimaging.bsky.social @inflames-flagship.bsky.social @turkubioscience.bsky.social
056
InFLAMES Research Flagship @inflames-flagship.bsky.social · 29/04/2026
Happy wishes from InFLAMES Flagship Finland on a International Day of Immunology! #ImmunoSky #medsky #FinnishFlagships @utu.fi @aboakademi.bsky.social @iuis-online.bsky.social @yefis-immunology.bsky.social @yssi-immunology.bsky.social
011
InFLAMES Research Flagship @inflames-flagship.bsky.social · 21/04/2026
Soon we´ll have a chance to listen to our new clinical researchers Lauri Ivaska, Jukka Kero and Eero Rissanen. Excellent! #Medsky #ImmunoSky #Science #immunology @lauriivaska.bsky.social @utu.fi
Ad for a event with the pictures of the lecturers.
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 20/04/2026
Let´s talk about #diabetes tsunami with Raivo Uibo.
000
InFLAMES Research Flagship @inflames-flagship.bsky.social · 02/04/2026
Ryhmänjohtajamme, professori Jukka Westermarckin johtama tutkimus on saanut lähes miljoonan euron säätiörahoituksen, onnea🔥🍾💐👏! Rahoitus myönnettiin tutkimukseen, jossa etsitään lääkemolekyylikandidaatteja vakavaan kolmoisnegatiiviseen rintasyöpätyyppiin. Toivotamme parasta menestystä tutkimukselle!
inflames.utu.fi
Jukka Westermarckin johtamalle tutkimukselle lähes miljoonan euron rahoitus - InFLAMES-lippulaiva
Jane ja Aatos Erkon säätiö myönsi 993 000 € nelivuotisen rahoituksen syöpäbiologian professori, InFLAMES-lippulaivan ryhmänjohtaja Jukka Westermarckille. Jane ja Aatos Erkon säätiö myönsi vuoden ensim...
071
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 24/03/2026
One week time left to propose your life-science paper as the Elias Tillandz publication prize winner! Take a look at the details and send your proposal at latest 31 March 2026: biocityturku.fi/elias-tillan... @utu.fi @inflames-flagship.bsky.social @turkubioimaging.bsky.social
032
InFLAMES Research Flagship @inflames-flagship.bsky.social · 18/03/2026
Lääketieteen tohtori Antti Hurme on aloittanut Turun Immunologiakeskuksen kliinisenä johtajana! Hän aikoo toimia siltana immunologisen perustutkimuksen ja klinikan välillä. Onnea Antille! #ImmunoSky #MedSky #ScienceSky
inflames.utu.fi
Antti Hurme Turun Immunologiakeskuksen kliiniseksi johtajaksi – tavoitteena tutkimuksen ja klinikan yhdistäminen - InFLAMES-lippulaiva
Lääketieteen tohtori Antti Hurme aloitti Turun Immunologiakeskuksen kliinisenä johtajana helmikuussa 2026. Hän sanoo, että immunologiakeskus on juuri se mitä tarvitaan, jotta immunologista perustutkim...
010
Reposted by InFLAMES Research Flagship
Johanna Ivaska @johannaivaska.bsky.social · 20/02/2026
What music should we play to our cells? This was the start of an amazing journey from @ivaskalab.bsky.social at @turkubioscience.bsky.social with Jasmin Kaivola and collaborators @sarawickstrom.bsky.social and others to explore larynx cancer mechanosensitivity! www.nature.com/articles/s41...
nature.com
Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties - Nature Materials
Vocal fold cancer tumours lose some of their malignant traits when mechanically stimulated by physiological stretch or vibrations, mimicking the opening and closing of vocal folds and phonation.
03216
InFLAMES Research Flagship @inflames-flagship.bsky.social · 18/02/2026
Our researchers have discovered that the surface cells of the lymphatic vessels in oral cancer contain proteins that indicate cell division and strongly predict disease progression and mortality. @salmilab.bsky.social @turkubioscience.bsky.social #ImmunoSky #MedSky
inflames.utu.fi
Aggressive oral cancer can be identified at an early stage by changes in lymphatic vessels - InFLAMES Research Flagship
Oral cancers with a high risk of recurrence can be identified at an early stage by examining the lymphatic vessels of the tumour. Finnish researchers have discovered for the first time that the surfac...
010
InFLAMES Research Flagship @inflames-flagship.bsky.social · 16/02/2026
Exciting times! Over 80 international researchers applied to the IMMUFELLOW postdoctoral research programme for immunology-related postdoctoral positions. The applications are currently under review by independent experts. #immunology @salmilab.bsky.social @utu.fi @aboakademi.bsky.social
inflames.utu.fi
Over 80 applications were received for the IMMUFELLOW program - InFLAMES Research Flagship
Over 80 international researchers applied for the IMMUFELLOW postdoctoral research programme. The first 11 positions were available at the University of Turku or Åbo Akademi University for immunology-...
021
Reposted by InFLAMES Research Flagship
rantakarigroup.bsky.social @rantakarigroup.bsky.social · 12/02/2026
Glad to see the increased interest in sex differences among immunologist. See you in the meeting. @inflames-flagship.bsky.social @utu.fi @univcotedazur.bsky.social
011
Reposted by InFLAMES Research Flagship
BioCity Turku @biocityturku.bsky.social · 09/02/2026
#biocityturkuannounceent 7-8/26 This week * MBC Bioinformatics Journal Club, 11Feb at 13:00 * FICAN Science Webinar, 11Feb at 15:00 * Frontiers of Science, 12Feb at 12:00, Bentires-Alj Full version: bit.ly/3ZlegaR @utu.fi @turkubioscience.bsky.social @inflames-flagship.bsky.social
011
Reposted by InFLAMES Research Flagship
Dr. Salla-Maaria Laaksonen @sallamaaria.eurosky.social · 05/02/2026
Spent the morning in Turku talking about #scicomm on social media to doctoral researchers in @inflames-flagship.bsky.social. These sessions are insightful and meaningful for me, love hearing the research topics and thoughts of these future stars! Hope to meet many of them online soon!
Introduction slide that reads "Why bother? Science communication on social media" with an illustration of the tablet and varous science-related drawings on the right. Yellow background.
151
Reposted by InFLAMES Research Flagship
EFIS_Immunology @efis-immunology.bsky.social · 21/01/2026
🌟14th EFIS-EJI TATRA Immunology Conference 💡Proudly supported by #EFIS and @eurjimmunol.bsky.social 🤝organized by the 🇦🇹,🇨🇿+🇸🇰 Immunological Societies 📚unites Europe’s rising #immunology stars since 1994 👉 tatra.img.cas.cz Be part of this community shaping the future of immunology & spread the word!
177
Reposted by InFLAMES Research Flagship
Academic Europe @academiceurope.bsky.social · 29/01/2026
Job Alert Postdoctoral Fellow – Cancer Immunology (100%) Location - Basel www.academiceurope.com/ads/postdoct... #hiring #cancerresearch #immunology #postdoc #oncology #biology #biomedicine
031
Reposted by InFLAMES Research Flagship
rantakarigroup.bsky.social @rantakarigroup.bsky.social · 03/02/2026
We are glad to see that the research on women's health issues have finally come to spotlight around the world @inflames-flagship.bsky.social
021
InFLAMES Research Flagship @inflames-flagship.bsky.social · 30/01/2026
Lääketieteessä ja lääkekehityksessä tutkimus on painottunut miehiin. Mutta onko niin, että miesbiologiasta kumpuavat tutkimustulokset ovat suoraan sovellettavissa naisiin? Mm. tätä pohdittiin InFLAMESin Sex and Immunity-teeman Corporate Corner -seminaarissa. #ImmunoSky #MedSky #immunologia
utu.fi
Nainen ei ole koskaan sama, ja on siksi biotietieteille hankala tutkimuskohde
Kaikki ihmiset eivät tunnetusti ole miehiä, mutta lääketieteellistä ja lääketutkimusta on tehty pitkälti heillä. Tulosten on oletettu pätevän myös naisiin, vaikka näin ei välttämättä ole.
041
InFLAMES Research Flagship @inflames-flagship.bsky.social · 30/01/2026
Ryhmänjohtamme, neuroimmunologian professori Laura Airas kertoo Turun Sanomissa monin tavoin yllättävästä MS- lääketutkimuksesta! #lääkekehitys #MedSky #ImmunoSKY #MS @utu.fi
000